Guangxi Shenguan Collagen Biological Group Company Limited（广西神冠胶原生物集团有限公司）is a globally recognized enterprise specializing in the research, production, and application of collagen-based products. Headquartered in Wuzhou, Guangxi, China, Shenguan is widely known as the world's largest manufacturer of edible collagen sausage casings and a leading innovator in collagen biotechnology for food, health, medical, and cosmetic applications.
Core Business
Shenguan Group's core business spans the full collagen industry chain—from collagen extraction to the development of advanced applications in food technology, healthcare, and medical devices. The company is committed to unlocking the full potential of collagen biomaterials by integrating modern biotechnology with traditional collagen processing techniques.
Product and Service Offerings
-
Edible Collagen Sausage Casings
- World-leading production of smoked, colored, dried, and fresh collagen casings
- Used extensively by meat processors for industrial sausage production
- Known for high mechanical strength, uniform thickness, and excellent permeability
-
Collagen Food Products
- Functional foods such as collagen-infused rice noodles, beef tendon snacks, collagen oatmeal
- Collagen drinks and powders developed for anti-aging and joint health
-
Collagen Skincare Products
- High-purity collagen face masks, collagen extracts, and serums
- Branded under the Shenguan Superior skincare line, targeting anti-aging and hydration markets
-
Collagen Medical Devices
- Artificial bone materials for orthopedics and dental applications
- Wound healing solutions including band-aids, in vivo absorbable hemostatic dressings, and sterile pads
- Medical aesthetic collagen products used in minimally invasive beauty procedures
Specialization and Core USP
Shenguan's competitive edge lies in:
- Being the world's largest producer of edible collagen casings, with over 60% global market share
- Vertically integrated production, controlling raw material sourcing, extraction, purification, and product development
- Strong in-house R&D capability, with over 100 patents and multiple proprietary collagen processing technologies
- Comprehensive product portfolio covering food, cosmetic, medical, and health care collagen applications
Financial Performance
Guangxi Shenguan Collagen Biological Group is publicly listed on the Hong Kong Stock Exchange (HKEX: 0829.HK). As of its latest financial report:
- Revenue for FY2022 was approximately RMB 1.37 billion (USD 190 million)
- Net profit was approximately RMB 300 million
- Majority revenue contribution from collagen casings (approx. 80%), with rapid growth in collagen healthcare and cosmetic sectors
These financials underscore Shenguan’s dominance in traditional collagen markets and its expansion into high-value verticals.
Shipment and Export Records
According to trade and company reports:
- Shenguan exports its collagen casings and products to over 30 countries
- Key markets include North America, Europe, South America, Russia, and Southeast Asia
- Annual export volume of collagen casings surpasses 15,000 metric tons
- Collaborations with global meat processing giants and food manufacturers
Target Markets
Shenguan’s target markets include:
- Meat processing companies (for industrial sausage production)
- Nutraceutical brands seeking high-quality collagen raw materials
- Cosmetic and skincare companies looking for bioactive collagen
- Hospitals, clinics, and medical device distributors in orthopedic and wound care sectors
Capabilities
- Large-scale production facilities equipped with automated, hygienic collagen casing lines
- National-level collagen R&D center with biomaterials labs and application testing
- Collaboration with top Chinese universities for collagen drug delivery and regenerative medicine research
- Annual capacity of 18 billion meters of collagen casings
Certifications and Compliance
- ISO 9001 and ISO 22000 Quality and Food Safety Management Systems
- GMP-certified facilities for food, cosmetic, and medical production
- CE and FDA registrations for specific medical products
- Products comply with EU and US food-grade standards, including halal and kosher certifications
Customer Testimonials
Industry endorsements and client partnerships emphasize:
- “Consistently high-quality collagen casings meeting international specifications”
- “Reliable logistics and documentation for global compliance”
- “Strong R&D partner in co-developing collagen functional products”
Shenguan’s long-term collaborations with global food and healthcare brands reflect a strong trust in product consistency and innovation.
Major Achievements
- Recognized as a "Key National High-Tech Enterprise" in China
- Developed China’s first collagen artificial bone material, approved for clinical application
- Listed as Top 100 Biotechnology Enterprises in China
- Annual investment of over RMB 100 million in R&D for advanced collagen biomaterials
- Established Shenguan Biotechnology Research Institute focused on regenerative medicine and anti-aging technologies
Guangxi Shenguan Collagen Biological Group continues to lead the global collagen industry through innovation, scale, and diversification—positioning itself as a transformative force in functional biomaterials for the future of food, medicine, and wellness.
